Vaidya Sane Ayurved Laboratories Ltd.

Financial

	Vaidya Sane Ayur Lab	Balaxi Pharma.	Kimia Biosciences
Operational Metrics
Financials
5 yr Average ROE	8.39 %	27.3 %	-352.38 %
5yr average Equity Multiplier	1.34	1.4	65.1
5yr Average Asset Turnover Ratio	1.57	1.43	1.17
5yr Avg Net Profit Margin	3.83 %	11.03 %	-2.03 %
Price to Book	0.0	1.13	0.0
P/E	36.08	9.45	27.34
5yr Avg Cash Conversion Cycle	-76.76 Days	154.28 Days	28.76 Days
Inventory Days	11.33 Days	87.41 Days	94.07 Days
Days Receivable	24.16 Days	103.86 Days	101.18 Days
Days Payable	116.68 Days	63.18 Days	144.79 Days
5yr Average Interest Coverage Ratio	6.88	57.05	0.28
5yr Avg ROCE	12.91 %	36.52 %	-0.98 %
5yr Avg Operating Profit Margin	7.94 %	16.64 %	1.32 %
5 yr average Debt to Equity	0.02	0.09	29.7
5yr CAGR Net Profit	-10.61 %	-5.76 %	n/a
5yr Average Return on Assets	6.19 %	18.47 %	-2.12 %
Shareholdings
Promoter Holding	66.34 %	65.99 %	74.94 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-6.87 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Vaidya Sane Ayur Lab	Balaxi Pharma.	Kimia Biosciences
Location Wise Break-Up	Location Wise Break-Up India 0 Guatemala 0 Dominican Republic 0 Angola 0 International 0 Domestic 0 Others 100	Location Wise Break-Up Dominican Republic 22.73 Domestic 0 Angola 21.15 Guatemala 29.72 India 0 International 0 Others 26.4	Location Wise Break-Up Dominican Republic 0 Domestic 80.69 Angola 0 Guatemala 0 India 0 International 19.31
Operating Profit Break-Up	Operating Profit Break-Up Sale of Products 71.76 Hospital Activity 28.24	-	-
Capex	Capex Hospital Activity 100.0 Sale of Products 0	-	-
Asset Break-Up	Asset Break-Up Hospital Activity 100.0 Sale of Products 0	-	-
Segment Wise Break-Up	Segment Wise Break-Up Sale of Products 64.42 Hospitals 26.63 Others 8.95	-	-